Excelsior Medical Co., Ltd. (TPE:4104)
Taiwan
· Delayed Price · Currency is TWD 88.30
+0.20 (0.23%)
Apr 2, 2025, 1:35 PM CST
Excelsior Medical Revenue
In the year 2024, Excelsior Medical had annual revenue of 8.54B TWD with 3.71% growth. Excelsior Medical had revenue of 2.28B in the quarter ending December 31, 2024, with 4.26% growth.
Revenue
8.54B
Revenue Growth
+3.71%
P/S Ratio
1.69
Revenue / Employee
61.87M
Employees
138
Market Cap
14.43B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 8.54B | 305.14M | 3.71% |
| Dec 31, 2023 | 8.23B | 1.05B | 14.56% |
| Dec 31, 2022 | 7.19B | 613.68M | 9.34% |
| Dec 31, 2021 | 6.57B | -102.34M | -1.53% |
| Dec 31, 2020 | 6.68B | 218.13M | 3.38% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PharmaEssentia | 9.73B |
| Caliway Biopharmaceuticals | 44.43M |
| Bora Pharmaceuticals Co., LTD. | 19.25B |
| Lotus Pharmaceutical | 18.58B |
| Oneness Biotech | 117.93M |
| Lumosa Therapeutics | 39.15M |
| Pegavision | 6.82B |
| Center Laboratories | 1.62B |